Individual Study / Ku-gaa-gii pimitizi-win

Ku-gaa-gii pimitizi-win COVID-19 Cohort Study
  1. Home
  2. Individual Studies
  3. Ku-gaa-gii pimitizi-win

Ku-gaa-gii pimitizi-win COVID-19 Cohort Study

Networks -
Datasets -
Variables -
Start Year
2021
End Year
2022
Visit Ku-gaa-gii pimitizi-win
Add to cart

Members

Download
Investigators Contacts
  • Dr. Stephen Hwang
    MAP Centre for Urban Health Solutions
  • Dr. Lucie Richard
    St. Michael's Hospital

Design

Study design
Cohort
Follow Up
Participants are followed-up every 3 months over a 12-month period, for a total of 5 study encounters (1 baseline encounter and 4 follow-up encounters).

Recruitment

Recruitment Target
  • Individuals

Number of Participants

Number of Participants
700
Number of Participants with Biological Samples
700

Access

Availability of data and biosamples

Possible Access to Data
Possible Access to Biosamples
Other
Yes
No
Not applicable
Don't know

Timeline

Ku-gaa-gii pimitizi-win population

Selection Criteria
Minimum age
16
Newborns
Twins
Countries
  • Canada
Territory
Toronto
Ethnic Origin
Health Status
Other Criteria
Inclusion: Identified as being homeless at the time of recruitment (unsheltered, emergency sheltered or provisionally accomodated), willing to participate in interviews and provide a finger-prick blood sample at baseline and each follow-up encounter, willing to be contacted by the research team for follow-up encounters

Recruitment

Sources of recruitment
  • Specific population
Specific Population
  • Other specific population : Homeless
Supplementary Information
Recruitment will occur over 3 months at over 110 physical distancing hotels and shelter programs for youth (age 16-24 years), adults, and families and at large encampment in the city of Toronto.

Number of Participants

Number of Participants
700
Number of Participants with Biological Samples
700
Data Collection Events
# Name Description Start End
0 Ku-gaa-gii pimitizi-win - Baseline Information on demographic, health (chronic medical conditions, weight, height), housing history, tobacco and e-cigarette use, alcohol use, drug use, COVID-19 vaccine uptake, reasons for COVID-19 ... 2021-01 2021-03
1 Ku-gaa-gii pimitizi-win - Follow-up 1 Information on demographic, health (chronic medical conditions, weight, height), housing history, tobacco and e-cigarette use, alcohol use, drug use, COVID-19 vaccine uptake, reasons for COVID-19 ... 2021-04 2021-06
2 Ku-gaa-gii pimitizi-win - Follow-up 2 Information on demographic, health (chronic medical conditions, weight, height), housing history, tobacco and e-cigarette use, alcohol use, drug use, COVID-19 vaccine uptake, reasons for COVID-19 ... 2021-07 2021-09
3 Ku-gaa-gii pimitizi-win - Follow-up 3 Information on demographic, health (chronic medical conditions, weight, height), housing history, tobacco and e-cigarette use, alcohol use, drug use, COVID-19 vaccine uptake, reasons for COVID-19 ... 2021-10 2021-12
4 Ku-gaa-gii pimitizi-win - Follow-up 4 Information on demographic, health (chronic medical conditions, weight, height), housing history, tobacco and e-cigarette use, alcohol use, drug use, COVID-19 vaccine uptake, reasons for COVID-19 ... 2022-01 2022-03

Classifications

Socio-demographic and economic characteristics
Lifestyle and behaviours
Birth, pregnancy and reproductive health history
Perception of health, quality of life, development and functional limitations
Diseases
Symptoms and signs
Medication and supplements
Non-pharmacological interventions
Health and community care services utilization
Death
Physical measures and assessments
Laboratory measures
Cognition, personality and psychological measures and assessments
Life events, life plans, beliefs and values
Preschool, school and work life
Social environment and relationships
Physical environment
Administrative information

Socio-demographic and economic characteristics

Age/birthdate
Sex/gender
Education
Residence
Birthplace
Citizenship and immigrant status
Ethnicity, race and religion
Labour force and retirement

Lifestyle and behaviours

Tobacco
Alcohol
Drugs

Diseases

Certain infectious and parasitic diseases (A00-B99)
Neoplasms (C00-D48)
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50-D89)
Endocrine, nutritional and metabolic diseases (E00-E90)
Diseases of the nervous system (G00-G99)
Diseases of the circulatory system (I00-I99)
Diseases of the respiratory system (J00-J99)
Diseases of the digestive system (K00-K93)
Diseases of the musculoskeletal system and connective tissue (M00-M99)
Diseases of the genitourinary system (N00-N99)

Symptoms and signs

Symptoms and signs involving the circulatory and respiratory systems (R00-R09)
Symptoms and signs involving the digestive system and abdomen (R10-R19)
Symptoms and signs involving cognition, perception, emotional state and behaviour (R40-R46)
Symptoms and signs involving speech and voice (R47-R49)
General symptoms and signs (R50-R69)

Medication and supplements

Medication and supplement intake
Posology and protocol of administration

Non-pharmacological interventions

Laboratory diagnosis interventions
Other and unspecified non-pharmacological interventions

Health and community care services utilization

Hospitalizations
Other health and community care

Physical measures and assessments

Anthropometry

Life events, life plans, beliefs and values

Beliefs and values

Social environment and relationships

Social network
Social participation

Physical environment

Built environment/neighbourhood characteristics
Biological exposure

Administrative information

Identifiers
Date and time-related information
Questionnaire and interview-related information